Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Post by Noloon Nov 15, 2019 6:59am
132 Views
Post# 30355056

I know in advance what Tripp's going to say

I know in advance what Tripp's going to sayto explain this mess.

1-Difficulties in billing due to name change.

2-Telehealth was not in place then. It has just started.

And by saying that, he might be truthful but the problem for us investors is that, for the next 5+ months, we will be navigating in complete darkness. Since we are rarely/never informed on the progress of sales, the people that stay will do so in a total act of faith. We will just take a chance and hope for the best. No research or DD or whatever can change a single thing about it.

As we speak, cash might be flowing in but we won't know for sure. Tripp will talk about 'lift off' but this is not tangible enough for investors after this Q3 report. 

So, like Indy in the Last Crusade: are we going to take the Leap of Faith?

Bullboard Posts